Developing Nasal Formulations for Novel Indications – Acute Suicidal Ideation
Time: 3:30 pm
day: Conference Day Two
Details:
- Understanding molecule PKPD and dose selection
- Administering your API intravenously vs nasally and the impact on your molecule for optimal results
- Evaluating toxicological challenges of intranasal CNS formulations for accelerated approval